Capsaicin in Pain Management A Spicy Solution to Chronic and Neuropathic Pain
DOI:
https://doi.org/10.12775/QS.2024.20.53267Keywords
capsaicin, capsaicin in pain relief, capsaicin in chronic pain treatment, capsaicin in neuropathy pain treatmentAbstract
Introduction and purpose:
Chronic pain, defined as pain persisting for three months or longer and neuropathic pain which is a type that arises as a result of damage or disease to the somatosensory system, including peripheral fibers (Aβ, Aδ, and C fibers) and central neurons, are serious conditions pose significant challenges for modern medicine. Addressing these challenges often necessitates a multimodal approach to analgesia, involving the use of multiple analgesic agents with different mechanisms of action. Among these agents is capsaicin, a naturally occurring compound found in hot peppers. This study will collect and analyze information about the applications of capsaicin in pain management, its mechanisms of action, efficacy, and safety
Brief description of the state of knowledge:
Capsaicin is a natural compound found in chili peppers. This alkaloid is a highly selective agonist of the TRPV1 vanilloid receptor. Upon activation of these receptors, skin nociceptors become less sensitive to stimuli. Incorporating capsaicin into standard chronic and neuropathic pain management may enhance, expedite, and streamline the complex process of treatment, ultimately contributing to improved quality of life for patients and communities. It also offers certain benefits in the treatment of obesity, cardiovascular and gastrointestinal pathologies, various types of cancers, neurogenic bladder, and some dermatological conditions.
Materials and Methods:
Review and summary of research studies available in databases on Google Scholar and
PubMed.
Summary:
Topically applied capsaicin, especially in the form of an 8% patch is a valuable option for treating peripheral chronic and neuropathic pain, including bone and joint pain. The highest quality evidence has been presented in postherpetic neuralgia and HIV-related pain, where treatment efficacy is comparable to standard treatment.
References
Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain.
;10(4):287-333.
doi:10.1016/j.ejpain.2005.06.009
Colloca L, Ludman T, Bouhassira D, et al. Neuropathic pain. Nat Rev Dis Primers.
;3:17002. Published 2017 Feb 16.
doi:10.1038/nrdp.2017.2
Petroianu GA, Aloum L, Adem A. Neuropathic pain: Mechanisms and therapeutic strategies. Front Cell Dev Biol. 2023;11:1072629. Published 2023 Jan 16. doi:10.3389/fcell.2023.1072629
Silva JL, Santos EA, Alvarez-Leite JI. Are We Ready to Recommend Capsaicin for
Disorders Other Than Neuropathic Pain?. Nutrients. 2023;15(20):4469. Published
Oct 21.
doi:10.3390/nu15204469
Batiha GE, Alqahtani A, Ojo OA, et al. Biological Properties, Bioactive Constituents, and Pharmacokinetics of Some Capsicum spp. and Capsaicinoids. Int J Mol Sci.
;21(15):5179. Published 2020 Jul 22.
doi:10.3390/ijms21155179
Yang F, Zheng J. Understand spiciness: mechanism of TRPV1 channel activation by capsaicin. Protein Cell. 2017;8(3):169-177.
doi:10.1007/s13238-016-0353-7
Frias B, Merighi A. Capsaicin, Nociception and Pain. Molecules. 2016;21(6):797.
Published 2016 Jun 18.
doi:10.3390/molecules21060797
Munjuluri S, Wilkerson DA, Sooch G, Chen X, White FA, Obukhov AG. Capsaicin and TRPV1 Channels in the Cardiovascular System: The Role of Inflammation. Cells.
;11(1):18. Published 2021 Dec 22.
doi:10.3390/cells11010018
Lawrence GW, Zurawski TH, Dong X, Dolly JO. Population Coding of Capsaicin Concentration by Sensory Neurons Revealed Using Ca2+ Imaging of Dorsal Root Ganglia Explants from Adult pirt-GCaMP3 Mouse. Cell Physiol Biochem.
;55(4):428-448.
doi:10.33594/000000394
Rains C, Bryson HM. Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis. Drugs Aging. 1995;7(4):317-328.
doi:10.2165/00002512-199507040-00007
Kim-Katz SY, Anderson IB, Kearney TE, MacDougall C, Hudmon KS, Blanc PD. Topical antacid therapy for capsaicin-induced dermal pain: a poison center telephone-directed study. Am J Emerg Med. 2010;28(5):596-602. doi:10.1016/j.ajem.2009.02.007
Gašparini D, Ljubičić R, Mršić-Pelčić J. Capsaicin - Potential Solution for Chronic Pain Treatment. Psychiatr Danub. 2020;32(Suppl 4):420-428.
Webster LR, Malan TP, Tuchman MM, Mollen MD, Tobias JK, Vanhove GF. A multicenter, randomized, double-blind, controlled dose finding study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia. J Pain.
;11(10):972-982.
doi:10.1016/j.jpain.2010.01.270
Haanpää M, Treede RD. Capsaicin for neuropathic pain: linking traditional medicine and molecular biology. Eur Neurol. 2012;68(5):264-275. doi:10.1159/000339944
Backonja M, Wallace MS, Blonsky ER, et al. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study [published correction appears in Lancet Neurol. 2009 Jan;8(1):31].
Lancet Neurol. 2008;7(12):1106-1112.
doi:10.1016/S1474-4422(08)70228-X
Gonzalez-Duarte A, Robinson-Papp J, Simpson DM. Diagnosis and management of HIV-associated neuropathy. Neurol Clin. 2008;26(3):821-x. doi:10.1016/j.ncl.2008.04.00
Ferrari S, Vento S, Monaco S, et al. Human immunodeficiency virus-associated peripheral neuropathies. Mayo Clin Proc. 2006;81(2):213-219. doi:10.4065/81.2.213
Simpson DM, Brown S, Tobias J; NGX-4010 C107 Study Group. Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy.
Neurology. 2008;70(24):2305-2313.
doi:10.1212/01.wnl.0000314647.35825.9c
Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17(9):1113-e88. doi:10.1111/j.1468-1331.2010.02999.x
Jensen TS, Karlsson P, Gylfadottir SS, et al. Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management. Brain.
;144(6):1632-1645. doi:10.1093/brain/awab079
Feldman EL, Callaghan BC, Pop-Busui R, et al. Diabetic neuropathy. Nat Rev Dis
Primers. 2019;5(1):42. Published 2019 Jun 13. doi:10.1038/s41572-019-0097-9
Derry S, Rice AS, Cole P, Tan T, Moore RA. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev.
;1(1):CD007393. Published 2017 Jan 13. doi:10.1002/14651858.CD007393.pub4
Simpson DM, Robinson-Papp J, Van J, et al. Capsaicin 8% Patch in Painful Diabetic
Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study. J
Pain.
;18(1):42-53. doi:10.1016/j.jpain.2016.09.008
Vinik AI, Perrot S, Vinik EJ, et al. Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a
randomised, 52-week, open-label, safety study. BMC Neurol. 2016;16(1):251.
Published 2016 Dec 6. doi:10.1186/s12883-016-0752-7
Ayis S, Dieppe P. The natural history of disability and its determinants in adults with lower limb musculoskeletal pain. J Rheumatol. 2009;36(3):583-591. doi:10.3899/jrheum.080455
Bestwick-Stevenson T, Ifesemen OS, Pearson RG, Edwards KL. Association of
Sports Participation With Osteoarthritis: A Systematic Review and Meta-Analysis.
Orthop J Sports Med. 2021;9(6):23259671211004554. Published 2021 Jun 14. doi:10.1177/23259671211004554
Stevens RM, Ervin J, Nezzer J, et al. Randomized, Double-Blind, Placebo-Controlled
Trial of Intraarticular Trans-Capsaicin for Pain Associated With Osteoarthritis of the
Knee. Arthritis Rheumatol. 2019;71(9):1524-1533.
doi:10.1002/art.40894
Laslett LL, Jones G. Capsaicin for osteoarthritis pain. Prog Drug Res.
;68:277-291.
doi:10.1007/978-3-0348-0828-6_11
Boyette-Davis JA, Hou S, Abdi S, Dougherty PM. An updated understanding of the mechanisms involved in chemotherapy-induced neuropathy. Pain Manag.
;8(5):363-375.
doi:10.2217/pmt-2018-0020
Filipczak-Bryniarska I, Krzyzewski RM, Kucharz J, et al. High-dose 8% capsaicin patch in treatment of chemotherapy-induced peripheral neuropathy: single-center experience. Med Oncol. 2017;34(9):162. Published 2017 Aug 17.
doi:10.1007/s12032-017-1015-1
Maihöfner C, Diel I, Tesch H, Quandel T, Baron R. Chemotherapy-induced peripheral neuropathy (CIPN): current therapies and topical treatment option with high-concentration capsaicin. Support Care Cancer. 2021;29(8):4223-4238. doi:10.1007/s00520-021-06042-x
Anand P, Elsafa E, Privitera R, et al. Rational treatment of chemotherapy-induced peripheral neuropathy with capsaicin 8% patch: from pain relief towards disease modification. J Pain Res. 2019;12:2039-2052. Published 2019 Jul 3. doi:10.2147/JPR.S213912
Cabezón-Gutiérrez L, Custodio-Cabello S, Palka-Kotlowska M, Khosravi-Shahi P. High-Dose 8% Capsaicin Patch in Treatment of Chemotherapy-Induced Peripheral Neuropathy. A Systematic Review. J Pain Symptom Manage.
;60(5):1047-1054.e1.
doi:10.1016/j.jpainsymman.2020.06.026
Brown S, Simpson DM, Moyle G, et al. NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials. AIDS Res Ther. 2013;10(1):5.
Published 2013 Jan 28.
doi:10.1186/1742-6405-10-5
Arora V, Campbell JN, Chung MK. Fight fire with fire: Neurobiology of capsaicin-induced analgesia for chronic pain. Pharmacol Ther. 2021;220:107743.
doi:10.1016/j.pharmthera.2020.107743
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Konrad Pilarski, Adam Kucharski, Rafał Makuch, Alicja Chrościcka , Kamil Gała, Andrzej Czajka, Paweł Lenard, Sara Michalska, Martyna Dewicka, Alicja Maria Wawrzyniak
![Creative Commons License](http://i.creativecommons.org/l/by-nc-sa/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 132
Number of citations: 0